| 2921.43.15 | 00 | α, α, α-Trifluoro-2,6-dinitro-N,N-dipropyl-p- toluidine (Trifluralin) | kg | 6.5% | Free (A,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX,P) 2.9% (SG) | 15.4￠/kg + 48.5% |
| 2921.43.19 | 00 | α, α, α-Trifluoro-o-toluidine; and α, α, α-Trifluoro-6-chloro-m-toluidine | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, L,MA,MX,P) 0.1￠/kg + 3.3% (SG) | 15.4￠/kg + 60% |
| 2921.43.22 | 00 | N-Ethyl-N-(2-methyl-2-propenyl)-2,6- dinitro-4-(trifluoromethyl)benzenamine | kg | 6.5% | Free (A,AU,BH,CA, CL,D,E,IL,J, JO,MA,MX,P) 0.1￠/kg + 3.3% (SG) | 15.4￠/kg + 60% |
| 2921.43.24 | 00 | 2-Amino-5-chloro-4-ethylbenzenesulfonic acid; 2-Amino-5-chloro-p-toluenesulfonic acid; p-Nitro-o-toluidine; and 3-(Trifluoromethyl)aniline (m-Aminobenzotrifluoride) | kg | Free | | 15.4￠/kg + 60% |
| 2923.20.10 | 00 | Purified egg phospholipids, pharmaceutical grade meeting requirements of the U.S. Food and Drug Administration, for use in intravenous fat emulsion | kg | Free | | 16.5￠/kg + 30% |
| 2924.21.08 | 00 | 1,1-Dimethyl-3-( α, α, α-trifluoro-￠/tolyl)urea (Fluometuron) | kg | Free | | 15.4￠/kg + 40.5% |
| 2924.29.28 | 00 | N-[[(4-Chlorophenyl)amino]carbonyl]-2,6- difluorobenzamide; and 3,5-Dichloro-N-(1,1-dimethyl-2-propynyl)- benzamide (Pronamide) | kg | Free | | 15.4￠/kg + 64.5% |
| 2926.90.16 | 00 | [1 α(S*),3 α(Z)]-( ± )-Cyano(3-phenoxyphenyl)- methyl 3-(2-chloro-3,3,3-trifluoro-1-propenyl)- 2,2-dimethylcyclopropanecarboxylate | kg | Free | | 15.4￠/kg + 64.5% |
| 2926.90.19 | 00 | N,N-Bis(2-cyanoethyl)aniline; and 2,6-Difluorobenzonitrile | kg | Free | | 15.4￠/kg + 65.5% |
| 2929.10.27 | 00 | N-Butylisocyanate; Cyclohexyl isocyanate; 1-Isocyanato-3-(trifluoromethyl)benzene; 1,5-Naphthalene diisocyanate; and Octadecyl isocyanate | kg | Free | | 15.4￠/kg + 52% |
| 2933.19.04 | 00 | Aromatic or modified aromatic: | | | | |
| 2933.19.15 | 00 | 1,2-Dimethyl-3,5-diphenyl-1H-pyrazolium methyl sulfate (Difenzoquat methyl sulfate) | kg | Free | | 15.4￠/kg + 48.5% |
| 2933.29.05 | 00 | Aromatic or modified aromatic: | | | | |
| 2933.29.05 | 00 | 1-[1-((4-Chloro-2-(trifluoromethyl)phenyl)- imino)-2-propoxyethyl]-1H-imidazole (Triflumizole); and Ethylene thiourea | kg | Free | | 15.4￠/kg + 52% |
| 2933.33.00 | 00 | Alfentanil (INN), anileridine (INN), bezitramide (INN), bromazepam (INN), difenoxin (INN), diphenoxylate (INN), dipipanone (INN), fentanyl (INN), ketobemidone (INN), methylphenidate (INN), pentazocine (INN), pethidine (INN), pethidine (INN) intermediate A, phencyclidine (INN) (PCP), phenoperidine (INN), pipradrol (INN), piritramide (INN), propiram (INN) and trimeperidine (INN); salts thereof | kg | Free | | 15.4￠/kg + 149.5% |
| 2933.49.17 | 00 | Ethyl ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-3- quinolinecarboxylate | kg | Free | | 15.4￠/kg + 52% |
| 2933.59.10 | 00 | Aromatic or modified aromatic: | | | | |
| 2933.59.21 | 00 | Aromatic or modified aromatic: | | | | |
| 2933.59.70 | 00 | Aromatic or modified aromatic: | | | | |
| 2933.79.04 | 00 | Aromatic or modified aromatic: | | | | |
| 2933.99.01 | 00 | Aromatic or modified aromatic: | | | | |
| 2933.99.01 | 00 | Butyl (R)-2-[4-(5-trifluoromethyl-2- pyridinyloxy)phenoxy]propanoate | kg | Free | | 15.4￠/kg + 50% |
| 2933.99.42 | 00 | Acriflavine; Acriflavine hydrochloride; Carbadox; and Pyrazinamide | kg | Free | | 15.4￠/kg + 46% |
| 2934.10.10 | 00 | Aromatic or modified aromatic: | | | | |
| 2934.30.12 | 00 | 2-(Trifluoromethyl)phenothiazine | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4￠/kg + 45% |
